Search - tctmd.com

Displaying 1 - 20 of 147

Sort: Relevancy | Date

Presentation TCT 2025

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Presenter: Michael J. Mack

October 27, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement Is Associated With Lower Risk of Aortic Dissection Compared to Surgical Aortic Valve Replacement: A Propensity Score-Matched Analysis

Presenter: Mohamed Doma

June 27, 2025

Presentation NY Valves 2025

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

Presenter: Robin Le Ruz

June 25, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low-Risk Patients at 5 Years: An Updated Meta-Analysis of Randomized Controlled Trials

Presenter: Sunny Goel

June 25, 2025

Presentation TCT 2024

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

Presenter: José Antonio Baz Alonso

October 29, 2024

Presentation TCT 2024

TCT 890: Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years: A Meta-Analysis of Randomized Trials

Presenter: John Connolly

October 28, 2024

Presentation TCT 2024

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

Presenter: Sunny Goel

October 27, 2024

Presentation TCT 2024

TCT 146: Impact of Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement

Presenter: Kazuki Suruga

October 27, 2024

Presentation TCT 2024

TCT 761: Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Systematic Review and Meta-Analysis

Presenter: Prakash Upreti

October 27, 2024

Presentation NY Valves 2024

Management of Aortic Stenosis in Low-Risk Patients – Current Options and Controversies

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

The Costs of Low-Risk TAVR Implant and All-Cause, Long-Term Follow Up Care in the Medicare Fee-For-Service Population

Presenter: Kael Wherry

June 06, 2024

Presentation NY Valves 2024

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

Presenter: Ole De Backer

June 05, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

February 28, 2024

Presentation TCT 2023

TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Muhammad Adil Afzal

October 26, 2023

Presentation TCT 2023

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Presenter: Rebecca Hahn

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Presenter: Gorav Ailawadi

October 24, 2023

Presentation TCT 2023

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Presenter: Martin Leon

October 24, 2023

Presentation TVT 2023

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Presenter: Michael Mack

June 08, 2023

Advertisement

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Transcatheter Aortic Valve Replacement Is Associated With Lower Risk of Aortic Dissection Compared to Surgical Aortic Valve Replacement: A Propensity Score-Matched Analysis

Case Presentation: A Young Low-Risk Patient With Symptomatic Severe Tri-Leaflet Aortic Stenosis

Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low-Risk Patients at 5 Years: An Updated Meta-Analysis of Randomized Controlled Trials

TCT 788: Permanent Pacemaker Post-TAVR: A Prior Narrow QRS Not Always Means Low Risk

TCT 890: Transcatheter Aortic Valve Replacement in Low-Risk Patients at Four or More Years: A Meta-Analysis of Randomized Trials

TCT 141: Transcatheter Aortic-Valve Replacement (TAVR) Versus Surgical Aortic-Valve Replacement (SAVR) in Low-Risk Patients at Long Term Follow Up: Meta-Analysis of Randomized Controlled Trials

TCT 146: Impact of Prosthesis-Patient Mismatch in Young and Low-Risk Patients After Newer Generation Balloon-Expandable Transcatheter Aortic Valve Replacement

TCT 761: Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: A Systematic Review and Meta-Analysis

Management of Aortic Stenosis in Low-Risk Patients – Current Options and Controversies

The Costs of Low-Risk TAVR Implant and All-Cause, Long-Term Follow Up Care in the Medicare Fee-For-Service Population

A Randomized Comparison of TAVR and SAVR in Low-Risk Patients Aged 70 Years or Younger: Results From the NOTION-2 Trial

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Four-Year Outcomes From the EVOLUT Low Risk Trial

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Contrapoint: M-TEER in Lower Risk PMR Patients: Putting the “Pro” and “Cons” in Perspective

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content